Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma

NCT01021800 is registered in ClinicalTrials.gov with Blood Transfusion Centre of Slovenia as lead sponsor.

NCT NCT01021800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01021800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma
Lead sponsor
Blood Transfusion Centre of Slovenia
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2009
Completion date
December 31, 2012
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic tubular adenocarcinoma